Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Diseases 1

Interventions

Cisplatin 28 toripalimab 14 Radiotherapy 12 Gemcitabine 12 Capecitabine 11 Radiotherapy, Intensity-Modulated 10 pembrolizumab 9 Surgical Procedures, Operative 9 Docetaxel 9 tislelizumab 8 Carboplatin 7 Drug Therapy 6 Blood Specimen Collection 6 anlotinib 5 Taxes 5 Paclitaxel 5 Nivolumab 5 Fluorouracil 5 Cetuximab 5 130-nm albumin-bound paclitaxel 5 Thyroxine 4 Magnetic Resonance Spectroscopy 4 Cyclophosphamide 4 trametinib 3 sintilimab 3 camrelizumab 3 Radiation 3 Observation 3 Injections 3 Immune Checkpoint Inhibitors 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Thyroid (USP) × Head & Neck × Clear all

NCT07239674 2025-11-20

DELTA

West China Hospital

Phase 3 Not yet recruiting

Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡